Sarepta Therapeutics, Inc. Quarterly Other Assets, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Sarepta Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q2 2024.
  • Sarepta Therapeutics, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $74.7M, a 49.6% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $74.7M -$73.5M -49.6% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $83M -$96.8M -53.8% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $77.7M -$72.2M -48.2% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $154M +$23.7M +18.1% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $148M +$18.9M +14.6% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $180M +$39.4M +28.1% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $150M +$863K +0.58% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $131M -$17.2M -11.6% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $129M -$12.3M -8.71% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $140M -$34.7M -19.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $149M -$64.3M -30.1% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $148M -$16.7M -10.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $142M +$27.2M +23.8% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $175M +$78.8M +82% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $213M +$131M +160% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $165M +$85.6M +108% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $114M +$3.64M +3.28% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $96.2M -$40.1M -29.4% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $81.9M +$4.13M +5.3% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $79M +$24.2M +44.2% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $111M +$67.8M +158% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $136M +$105M +337% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $77.8M +$41.3M +113% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $54.8M +$27.8M +103% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $43M +$14.4M +50.5% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $31.2M +$8.46M +37.2% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $36.5M +$9.62M +35.8% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $27M +$5.03M +22.9% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $28.6M +$13.3M +86.7% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $22.7M +$5.86M +34.7% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $26.9M +$9.52M +54.7% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $22M +$2.54M +13% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $15.3M -$7.79M -33.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $16.9M -$7.53M -30.8% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $17.4M -$17.7M -50.4% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $19.5M -$6.97M -26.4% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $23.1M +$7.19M +45.2% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $24.4M +$15.3M +169% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $35M +$32M +1045% Dec 31, 2014 10-K 2016-02-25
Q3 2014 $26.4M +$23.6M +842% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $15.9M +$10.2M +180% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $9.08M +$6.06M +200% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $3.06M +$1.53M +99.5% Dec 31, 2013 10-K 2015-02-26
Q3 2013 $2.81M +$1.11M +65.3% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $5.68M +$4.12M +264% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $3.02M +$1.1M +57.1% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $1.53M -$113K -6.86% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $1.7M +$376K +28.4% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $1.56M +$618K +65.5% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $1.92M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $1.65M +$622K +60.7% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $1.32M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $943K Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $1.03M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.